Xanthus Pharmaceuticals Ltd was a biopharmaceutical company focused on the discovery, development and acquisition of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
The company had a broad portfolio of drug candidates that advanced into preclinical and clinical development.
In 2008 Xanthus Pharmaceuticals Ltd was acquired by Antisoma plc, a company publicly traded on the London Stock Exchange (LSE:ASM).
Location: United States
Investors 1
| Date | Name | Website |
| - | NeoMed Man... | neomed.net... |